Controlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: Continuous infusion and bolus injection

The efficacy of recombinant activated factor VII (rFVIIa, NovoSeven) in five haemophiliacs (four haemophilia A, one haemophilia B), with high inhibitors ranging from 70 to 1900 Bethesda units, was evaluated. The treatment regimen was divided into two groups: group I, continuous infusion of 16.5 μg h...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Chuansumrit, P. Isarangkura, P. Angchaisuksiri, N. Sriudomporn, K. Tanpowpong, P. Hathirat, L. N. Jorgensen
Other Authors: Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Format: Article
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/26259
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University